YA
Yarrow Bioscience Inc
YARW · NASDAQ
$28.77 -3.71% (-$1.11)
1M -28.35%
Market Cap $494.7K
P/E Ratio -
Div. Yield 1.40%
ROE 70.23%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.02x
P/S 1.03x
EV/EBITDA N/A
Growth
40 /100
Stable Book val. growth 3.82%
Rev. growth 6.12%
FCF growth N/A
Profitability
0 /100
Weak Net margin 3,881.54%
Op. margin 4,134.65%
FCF margin 3,513.07%
Quality
0 /100
Poor ROE 70.23%
ROA 79.26%
Asset turnover 0.02x
Debt
100 /100
Low Current ratio 15.26x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
47 /100
Moderate Rev. volatility 15.79%
EPS volatility 21.15%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na YARW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rebecca Velez Frey
Employees
10
Headquarters
New Haven
Nadcházející události
05 LIS
Earnings
Upcoming earnings report